SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-057853
Filing Date
2022-02-28
Accepted
2022-02-28 16:05:53
Documents
14
Period of Report
2022-02-28
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d151986d8k.htm   iXBRL 8-K 27994
2 EX-10.1 d151986dex101.htm EX-10.1 87495
6 GRAPHIC g151986g42h40.jpg GRAPHIC 4860
  Complete submission text file 0001193125-22-057853.txt   273035

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bvs-20220228.xsd EX-101.SCH 2860
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE bvs-20220228_lab.xml EX-101.LAB 18738
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bvs-20220228_pre.xml EX-101.PRE 11711
8 EXTRACTED XBRL INSTANCE DOCUMENT d151986d8k_htm.xml XML 3471
Mailing Address 4721 EMPEROR BOULEVARD, SUITE 100 DURHAM NC 27703
Business Address 4721 EMPEROR BOULEVARD, SUITE 100 DURHAM NC 27703 (919) 474-6700
Bioventus Inc. (Filer) CIK: 0001665988 (see all company filings)

IRS No.: 810980861 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37844 | Film No.: 22689317
SIC: 3841 Surgical & Medical Instruments & Apparatus